CYAD Annual EBITDA
-$41.37 M
-$12.12 M-41.42%
31 December 2022
Summary:
As of February 5, 2025, CYAD annual earnings before interest, taxes, depreciation & amortization is -$41.37 million, with the most recent change of -$12.12 million (-41.42%) on December 31, 2022. During the last 3 years, it has fallen by -$11.70 million (-39.42%).CYAD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYAD Quarterly EBITDA
-$6.84 M
+$1.59 M+18.87%
30 June 2022
Summary:
As of February 5, 2025, CYAD quarterly earnings before interest, taxes, depreciation & amortization is -$6.84 million, with the most recent change of +$1.59 million (+18.87%) on June 30, 2022. Over the past year, it has increased by +$485.40 thousand (+6.63%).CYAD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYAD TTM EBITDA
-$28.72 M
+$485.40 K+1.66%
30 June 2022
Summary:
As of February 5, 2025, CYAD TTM earnings before interest, taxes, depreciation & amortization is -$28.72 million, with the most recent change of +$485.40 thousand (+1.66%) on June 30, 2022. Over the past year, it has dropped by -$10.72 million (-59.56%).CYAD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYAD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.4% | +6.6% | -59.6% |
| 3 y3 years | -39.4% | - | - |
| 5 y5 years | +22.7% | - | - |
CYAD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +366.4% | -217.2% | >+9999.0% |
Celyad Oncology SA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$41.37 M(+41.4%) | - | - |
| June 2022 | - | -$6.84 M(-18.9%) | -$28.72 M(-1.7%) |
| Mar 2022 | - | -$8.43 M(+75.2%) | -$29.20 M(-6.3%) |
| Dec 2021 | -$29.26 M(+71.5%) | -$4.81 M(-44.4%) | -$31.18 M(+51.8%) |
| Sept 2021 | - | -$8.64 M(+18.0%) | -$20.54 M(+14.1%) |
| June 2021 | - | -$7.32 M(-29.6%) | -$18.00 M(+68.6%) |
| Mar 2021 | - | -$10.41 M(-278.3%) | -$10.68 M(+3849.5%) |
| Dec 2020 | -$17.06 M(-42.5%) | $5.84 M(-195.6%) | -$270.30 K(-95.6%) |
| Sept 2020 | - | -$6.11 M | -$6.11 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$29.68 M(-30.7%) | - | - |
| Dec 2018 | -$42.81 M(-20.0%) | - | - |
| Dec 2017 | -$53.51 M(+119.9%) | - | - |
| Dec 2016 | -$24.33 M(-21.9%) | - | - |
| Dec 2015 | -$31.15 M(+50.5%) | - | - |
| Dec 2014 | -$20.69 M(+18.3%) | - | - |
| Dec 2013 | -$17.50 M(+13.4%) | - | - |
| Dec 2012 | -$15.43 M(+74.0%) | - | - |
| Dec 2011 | -$8.87 M | - | - |
FAQ
- What is Celyad Oncology SA annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Celyad Oncology SA?
- What is Celyad Oncology SA annual EBITDA year-on-year change?
- What is Celyad Oncology SA quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Celyad Oncology SA?
- What is Celyad Oncology SA quarterly EBITDA year-on-year change?
- What is Celyad Oncology SA TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Celyad Oncology SA?
- What is Celyad Oncology SA TTM EBITDA year-on-year change?
What is Celyad Oncology SA annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CYAD is -$41.37 M
What is the all time high annual EBITDA for Celyad Oncology SA?
Celyad Oncology SA all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.87 M
What is Celyad Oncology SA annual EBITDA year-on-year change?
Over the past year, CYAD annual earnings before interest, taxes, depreciation & amortization has changed by -$12.12 M (-41.42%)
What is Celyad Oncology SA quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CYAD is -$6.84 M
What is the all time high quarterly EBITDA for Celyad Oncology SA?
Celyad Oncology SA all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.84 M
What is Celyad Oncology SA quarterly EBITDA year-on-year change?
Over the past year, CYAD quarterly earnings before interest, taxes, depreciation & amortization has changed by +$485.40 K (+6.63%)
What is Celyad Oncology SA TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CYAD is -$28.72 M
What is the all time high TTM EBITDA for Celyad Oncology SA?
Celyad Oncology SA all-time high TTM earnings before interest, taxes, depreciation & amortization is -$270.30 K
What is Celyad Oncology SA TTM EBITDA year-on-year change?
Over the past year, CYAD TTM earnings before interest, taxes, depreciation & amortization has changed by -$10.72 M (-59.56%)